Advertisement

Public and patient usage and expectations for clinical trial registries

  • Kenneth Getz

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    De Angelis C, Drazen JM, Frizelle FA et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Available at www.icmje.org (Accessed: 29 January 2006)Google Scholar
  2. 2.
    Hayward R, Kent D, Vijan S, Hofer TP (2005) Reporting clinical trial results to inform providers, payers and consumers. Health Affairs 24: 1571–1581PubMedCrossRefGoogle Scholar
  3. 3.
    Fisher CB (2006) Clinical trial results databases: Unanswered questions. Science 311: 180–181PubMedCrossRefGoogle Scholar
  4. 4.
    Office of the New York State Attorney General Eliot Spitzer. Major pharmaceutical firm concealed information. Available at http://www.oag.state.ny.us/press/2004/jun/jun2b_04.html (Accessed 17 March 2005)Google Scholar
  5. 5.
    United States Food and Drug Administration. Section 113 Food and Drug Administration Modernization Act of 1997. Available at: http://lhncbc.nlm.nih.gov/clin/113.html (Accessed 8 February 2006)Google Scholar
  6. 6.
    Manheimer E, Anderson D (2002) Survey of public information about ongoing clinical trials funded by industry: evaluation of completeness and accessibility. Br Med J 325: 528–531CrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2006

Authors and Affiliations

  • Kenneth Getz
    • 1
  1. 1.Tufts Center for the Study of Drug DevelopmentTufts UniversityUSA

Personalised recommendations